World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
71
Citations
25392
World Ranking
19942
National Ranking
9931

Overview

Peter F. Buckley is affiliated with the University of Tennessee Health Science Center in the United States. Their research focuses primarily on medicine, biochemistry, genetics, and molecular biology, with notable contributions to genetics and psychiatry and mental health. The scientist's work extensively covers schizophrenia research and treatment, genetic associations and epidemiology, genomics and rare diseases, genomic variations and chromosomal abnormalities, bipolar disorder and treatment, mental health and psychiatry, as well as mental health treatment and access.

Their recent published papers demonstrate engagement with key topics in psychiatric genetics and clinical guidelines. These papers include:

  • Mapping genomic loci implicates genes and synaptic biology in schizophrenia, 2022, Nature
  • Rare coding variants in ten genes confer substantial risk for schizophrenia, 2022, Nature
  • The American Psychiatric Association Practice Guideline for the Treatment of Patients With Schizophrenia, 2020, American Journal of Psychiatry
  • An International Adult Guideline for Making Clozapine Titration Safer by Using Six Ancestry-Based Personalized Dosing Titrations, CRP, and Clozapine Levels, 2021, Pharmacopsychiatry
  • Genome-Wide Association Studies of Schizophrenia and Bipolar Disorder in a Diverse Cohort of US Veterans, 2020, Schizophrenia Bulletin

Their frequent co-authors include Tim B. Bigdeli, Ayman H. Fanous, Mark Hyman Rapaport, Dolores Malaspina, and Douglas S. Lehrer. This indicates a collaborative research approach in psychiatric and genetic studies.

Publication venues where Peter F. Buckley regularly contributes include:

  • Schizophrenia Research
  • FOCUS The Journal of Lifelong Learning in Psychiatry
  • UNC Libraries
  • Nature
  • Pharmacopsychiatry

The scientist's main fields of study, Medicine and Biochemistry, Genetics and Molecular Biology, encompass various subfields such as Genetics and Psychiatry and Mental health, reflecting their interdisciplinary expertise. Their work addresses several key topics relevant to psychiatric disorders, especially schizophrenia and bipolar disorder, and integrates genomic research with clinical psychiatry practices.

Best Publications

  • Meta-Analysis of Cytokine Alterations in Schizophrenia: Clinical Status and Antipsychotic Effects

    Brian J. Miller;Peter Buckley;Wesley Seabolt;Andrew Mellor

  • Psychiatric Comorbidities and Schizophrenia

    Peter F. Buckley;Brian J. Miller;Douglas S. Lehrer;David J. Castle

  • Practice guideline for the treatment of patients with schizophrenia

    M. I. Herz;R. P. Liberman;T. H. McGlashan;J. A. Lieberman

  • Improvement in cognitive functions and psychiatric symptoms in treatment-refractory schizophrenic patients receiving clozapine

    Corinne Hagger;Peter Buckley;John T. Kenny;Lee Friedman

  • Meta-analysis of oxidative stress in schizophrenia

    Joshua Flatow;Peter Buckley;Brian J. Miller

  • The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update.

    Troy A. Moore;Robert W. Buchanan;Peter F Buckley;John A. Chiles

  • The Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2003 update.

    Alexander L. Miller;Catherine S. Hall;Robert W. Buchanan;Peter F Buckley

  • Negative symptoms of schizophrenia: a problem that will not go away

    S. M. Stahl;Peter F Buckley

  • Meta-Analysis of Lymphocytes in Schizophrenia: Clinical Status and Antipsychotic Effects

    Brian J. Miller;Bintou Gassama;Dale Sebastian;Peter Buckley

  • Lack of insight in schizophrenia: impact on treatment adherence.

    Peter F. Buckley;Donna A. Wirshing;Prameet Bhushan;Joseph M. Pierre

  • Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or Cul‐de‐sac?

    P. F. Buckley;S. M. Stahl

  • Insight and its relationship to violent behavior in patients with schizophrenia.

    Peter F. Buckley;Debra R. Hrouda;Lee Friedman;Stephen G. Noffsinger

  • Neurotrophins and schizophrenia.

    Peter F. Buckley;Sahebarao Mahadik;Anilkumar Pillai;Alvin Terry

  • Metabolic profiles of second-generation antipsychotics in early psychosis: Findings from the CAFE study

    Jayendra K. Patel;Peter F Buckley;Sandra Woolson;Robert M. Hamer

  • Brain Derived Neurotropic Factor in First –Episode Psychosis

    Peter F. Buckley;Anilkumar Pillai;Anilkumar Pillai;Denise Evans;Denise Evans;Edna Stirewalt

  • 1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: Clinical, neurodevelopmental, and cognitive correlates ☆

    Peter F. Buckley;Constance Moore;Helen Long;Conall Larkin

  • Medication nonadherence and treatment outcome in patients with schizophrenia or schizoaffective disorder with suboptimal prior response.

    Jean Pierre Lindenmayer;Hong Liu-Seifert;Pandurang M. Kulkarni;Bruce J. Kinon

  • Is there a characteristic pattern to the treatment history of clinic outpatients with borderline personality

    Andrew E. Skodol;Peter Buckley;Edward Charles

  • Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia.

    George Anderson;Michael Berk;Michael Berk;Seetal Dodd;Karl Bechter

  • When symptoms persist: clozapine augmentation strategies.

    Peter Buckley;Alexander L Miller;Jerry Olsen;David Garver

Frequent Co-Authors

David J. Castle
David J. Castle University of Tasmania
Steven A. McCarroll
Steven A. McCarroll Harvard University
Mark Hyman Rapaport
Mark Hyman Rapaport Emory University
Dolores Malaspina
Dolores Malaspina Icahn School of Medicine at Mount Sinai
Joseph P. McEvoy
Joseph P. McEvoy Augusta University
Carlos N. Pato
Carlos N. Pato Rutgers, The State University of New Jersey
Lee Friedman
Lee Friedman Texas State University
Matcheri S. Keshavan
Matcheri S. Keshavan Beth Israel Deaconess Medical Center
Brett A. Clementz
Brett A. Clementz University of Georgia
Michele T. Pato
Michele T. Pato SUNY Downstate Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As the medical field evolves, online degrees offer flexible and accelerated routes for students and working professionals. Many aspiring nurses and nurse practitioners choose online programs for convenience and speed. Those looking to advance quickly may benefit from enrolling in the fastest dnp program, which allows qualified nurses to earn a terminal nursing degree in less time than traditional pathways.

Accessibility is also important—some candidates seek out the easiest dnp programs to balance rigorous study with personal and professional commitments. For those aiming to enter the workforce rapidly, fast track lpn programs provide a quick entry point into nursing, with many curricula available online.

Mental health is a growing specialty, and students interested in this field can consider psych np online programs, which train professionals for advanced roles in psychiatric healthcare. Exploring these online degrees and career pathways can help you discover alternatives and specialties that align with your interests and lifestyle.

Best Scientists Citing Peter F. Buckley

Trending Scientists

Recently Published Articles